Issue 4, 1990

Imidazol-5-yl radicals as reactive intermediates

Abstract

Imidazol-5-yl radicals have been generated as reactive intermediates in reduction reactions e.g. the reduction of 5-bromo-1,2-dimethylimidazole with Na/NH3/ButOH and the reduction of 5-iodo- and 5-bromo-imidazole with Bu3SnH, to yield 1,2-dimethylimidazole. The imidazol-5-yl radical resulting from the Na/NH3/ButOH and Bu3SnH reduction of 5-bromo-1 -(but-3-en-1-yl)-2-methylimidazole has been trapped by exo-radical cyclisation to yield the bicyclic imidazole (7). Attempted SRN1 substitution reactions between nucleophiles and 5-bromo- and 5-iodo-1,2-dimethylimidazole were unsuccessful. The radical anions of 5-nitroimidazoles were shown not to dissociate to nitrite anions and the corresponding imidazol-5-yl radicals, thereby disproving a putative explanation for the generation of nitrite anions in the antimicrobial mode of action of 5-nitroimidazoles. A mechanism has been proposed to explain the release of nitrite in the mode of action of nitroimidazoles.13C NMR spectroscopy has been used to distinguish between 4- and 5-bromo- and -iodo-imidazoles.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 1, 1990, 919-924

Imidazol-5-yl radicals as reactive intermediates

W. R. Bowman and P. F. Taylor, J. Chem. Soc., Perkin Trans. 1, 1990, 919 DOI: 10.1039/P19900000919

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements